Skip to content
Home/Companies/MedTech/Sense Biodetection
SB

Sense Biodetection

MedTech·UK·Active·7yr hold

Sense Biodetection is a biotech company, headquartered in UK.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Sense Biodetection?

Sense Biodetection is currently owned by Cambridge Innovation Capital through CIC Fund I (2013 vintage), since 2019. Across its history, Sense Biodetection has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-07

Cambridge Innovation Capital
Most recent investor
Cambridge Innovation Capital
CIC Fund I · 2013 · VC
2 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusAcquired

Ownership history

2 ownership periods · co-invest detected

Active
Currently held by Cambridge Innovation Capital since 2019.
Co-invest · 2 holders · 2016 · present
Mercia Asset Management
Mercia Asset ManagementExited 2023
2016 · 2023 · Mercia Direct Investments · 2014 · Balance Sheet
Trade Sale · to
MOIC
–
Cambridge Innovation Capital
Cambridge Innovation CapitalActive
2019 · present · CIC Fund I · 2013 · VC
MOIC
–

More from CIC Fund I

Other portfolio companies in the same fund.

Seldon
Exited 2026
AI/MLUK· 2020
Gyroscope Therapeutics
Exited 2021
BiotechUK· 2019
to
PredictImmune
Exited 2024
HealthTechUK· 2019
Audio Analytic
Exited 2022
AI/MLUK· 2017
to
Cytora
Exited 2025
InsurTechUK· 2017
to
Riverlane
Active
Deep TechUK· 2017

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings